600222，上演“天地板”

Group 1 - The core point of the news is that Tai Long Pharmaceutical experienced significant stock price volatility, opening with a limit increase before dropping sharply and then recovering slightly by the end of the trading day [1] - After a week of suspension, Tai Long Pharmaceutical announced that its controlling shareholder, Tai Rong Investment, had reached an agreement with relevant parties regarding a potential change in company control, leading to the resumption of trading on December 9 [3] - On December 8, Tai Rong Investment and Zhengzhou Zhongsheng Industrial Group, a shareholder with over 5% stake, reached an agreement with Jiang Pharmaceutical Holdings regarding a share transfer and governance matters, which includes the transfer of 8.73% of the company's shares at a price of 11.043 yuan per share, totaling 553 million yuan [4] Group 2 - The agreement will establish a consistent action relationship between Tai Rong Investment and Jiang Pharmaceutical Holdings regarding major company decisions, solidifying Jiang Pharmaceutical Holdings' control over Tai Long Pharmaceutical [4] - If the share transfer and related agreements proceed smoothly, Jiang Pharmaceutical Holdings will hold 7.37% of the shares after the first transfer, and through the agreement, will control a total of 14.37% of the shares, resulting in a change of the controlling shareholder from Tai Rong Investment to Jiang Pharmaceutical Holdings [4]